|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1993-8-27
|
|
pubmed:abstractText |
To assess the developmental effects of desipramine (DMI) treatment on the electrocardiogram (ECG), we investigated serum concentrations of DMI ([DMI]), and its major active metabolite 2-hydroxydesipramine ([OHDMI]) and ECG parameters.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0890-8567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
798-804
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8340301-Adolescent,
pubmed-meshheading:8340301-Adult,
pubmed-meshheading:8340301-Antidepressive Agents, Tricyclic,
pubmed-meshheading:8340301-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:8340301-Child,
pubmed-meshheading:8340301-Depressive Disorder,
pubmed-meshheading:8340301-Desipramine,
pubmed-meshheading:8340301-Electrocardiography,
pubmed-meshheading:8340301-Female,
pubmed-meshheading:8340301-Heart Rate,
pubmed-meshheading:8340301-Humans,
pubmed-meshheading:8340301-Male,
pubmed-meshheading:8340301-Metabolic Clearance Rate,
pubmed-meshheading:8340301-Risk Factors
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
|
|
pubmed:affiliation |
Department of Psychiatry, Massachusetts General Hospital 02114.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
